Business Wire

Helena Announces Strategic Partnership With Energy Vault

20.7.2021 15:00:00 EEST | Business Wire | Press release

Share

Global problem-solving organization Helena and Energy Vault, the creator of renewable energy storage products that are transforming the world’s approach to utility-scale energy storage for grid resiliency, today announced a strategic partnership to identify additional opportunities for Energy Vault’s breakthrough waste remediation technologies as the company begins deployment of its innovative energy storage system worldwide.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210720005330/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Energy Vault Commercial Demonstration Unit - Arbedo-Castione, Switzerland. (Photo: Business Wire)

While supporting Energy Vault’s expansion through Helena’s vast network, the strategic partnership will focus on accelerating adoption by global energy providers of the company’s transformative technology, in particular its advanced material remediation innovations. The unique application of material science to the main energy storage medium – the composite blocks – enables the use of alternative materials to replace environmentally unfriendly substances like concrete, which accounts for 7-8% of greenhouse gas emissions. In addition, the technology can accommodate the recycling of various pre-existing waste materials, which in return helps large utility and industrial companies transform financial and environmental liabilities into infrastructure assets to support their transition to a fully circular economic approach. For example, coal ash waste and retired wind turbine blades can be re-directed from landfills into its custom-made composite blocks that anchor the company’s gravity-powered systems. By maximizing the use of locally sourced soil, sand and waste materials, including outputs from fossil fuel production, Energy Vault’s supply chain design reduces the impact of GHGs from the transport sector while increasing jobs for local economies, the end result being an end-of-life solution for materials that are difficult to break down and can have negative environmental consequences. This beneficial reuse eliminates waste and enables the continual use of local resources within the framework of a circular economy.

This work will build upon the technology and commercial partnership that it previously announced in 2019 with CEMEX Research Group, a subsidiary of global building materials company CEMEX, and supports the collaboration Energy Vault most recently announced earlier this month with leading global energy powerhouse Enel Green Power.

As part of the partnership, which began in late 2020, Helena also announced that it completed a $20 million investment in Energy Vault. Helena’s investment and partnership with Energy Vault is conducted through Helena’s for-profit arm, Helena Special Investments, which operates projects that implement solutions to societal problems through for-profit means. Helena has joined other investors including Saudi Aramco Energy Ventures, SoftBank Vision Fund, CEMEX Ventures, Idealab, and Neotribe Ventures. As part of its investment, Helena Founder and CEO Henry Elkus joined Energy Vault’s board of directors.

"Our job at Helena is to identify and implement solutions to the critical global problems of the next 50 years. It doesn’t get much more critical than radically improving energy storage. It is both a short-term solution to the problems we have seen recently in areas like Texas and a long-term necessity for the world to sustainably transition away from fossil fuels. We believe Energy Vault will play a fundamental role in furthering that transition,” said Helena Founder and CEO Henry Elkus. “We are also supporting Energy Vault’s strategy in addressing another essential problem – remediating waste. The company’s ability to use massive quantities of waste material to construct its systems only makes the impact more real and the business case more viable while also providing utilities a streamlined method to transition out of fossil fuel-based energy production and recycle legacy assets.”

“We are thrilled to partner with Helena in pursuit of our shared mission and mutual passion in accelerating the decarbonization of our planet,” said Robert Piconi, CEO and Co-Founder, Energy Vault. “Given Helena’s focus in taking on the most significant global challenges – in this case the global transition to clean energy production – we are grateful to have them alongside us as both strategic partner and investor. Helena and its global network are already making an impact toward our technology adoption, and our continued work together will help the world to take a vital step towards combating the negative impacts of climate change.”

About Helena

Helena is a global problem-solving organization. Through Helena Projects, Helena seeks to implement solutions to critical societal problems. Since its founding in 2015, Helena Projects have included: America In One Room, which garnered the attention of President Barack Obama and The New York Times for one of the most significant political experiments in U.S. history; Factory in the Sky, which supported the development and construction of the world’s first carbon capture factory; Shield, which worked to protect the electrical grid from foreign and domestic threats; and most recently The Covid Project, which supplied tens of millions units of medical supplies and personal protective equipment to frontline responders during the COVID-19 pandemic. To learn more about Helena, visit helena.org.

About Energy Vault

Energy Vault is the creator of renewable energy storage products that are transforming the world’s approach to utility-scale energy storage for grid resiliency. Applying conventional physics fundamentals of gravity and potential energy, the system combines an innovative crane design that lifts specially designed, massive composite blocks with a proprietary, cloud-based software platform which orchestrates the storage and discharge of electricity. Utilizing 100% eco-friendly materials at unprecedented economics, Energy Vault is accelerating the shift to a fully renewable world.

For more information about Energy Vault, please visit energyvault.com and @EnergyVaultInc.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Helena Media
Catherine Pope
1.855.438.3553
helena@ellecomm.com

Energy Vault Media
media@energyvault.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release

International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye